What is the dosage and treatment protocol for diarrhea using Pepto-Bismol (bismuth subsalicylate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bismuth Subsalicylate Dosage and Treatment Protocol for Diarrhea

For adults with diarrhea, bismuth subsalicylate (Pepto-Bismol) should be taken as 2 chewable tablets (262 mg each) every 30 minutes or 4 tablets every hour as needed, not exceeding 8 doses (16 tablets) in 24 hours. 1

Dosage Guidelines

Adults and Children 12 years and older:

  • Standard dosing: 2 chewable tablets (524 mg) every 30 minutes OR 4 chewable tablets (1048 mg) every hour 1
  • Maximum daily dose: 8 doses (16 tablets) in 24 hours 1
  • Duration: Use until diarrhea stops but not more than 2 days 1

Children under 12 years:

  • Consult a doctor before use 1

Treatment Protocol Algorithm

  1. Initial Assessment:

    • Determine severity of diarrhea (mild, moderate, severe)
    • Check for warning signs requiring medical attention (bloody stools, fever >101.3°F, severe abdominal pain)
  2. For Mild to Moderate Diarrhea:

    • Start with bismuth subsalicylate: 2 tablets every 30 minutes or 4 tablets every hour 1
    • Ensure adequate fluid intake with oral rehydration solutions 2
    • Continue until diarrhea resolves or for maximum of 2 days 1
  3. For Severe Diarrhea or No Improvement:

    • Consider switching to loperamide (more effective than bismuth subsalicylate) 3
    • Initial dose: 4 mg followed by 2 mg after each loose stool 2, 4
    • Maximum loperamide dose: 16 mg per day 2, 4
    • Seek medical attention if symptoms persist beyond 48 hours
  4. Hydration Protocol:

    • For mild-moderate dehydration: Oral rehydration solution 50-100 mL/kg over 3-4 hours 2
    • For adults: 2-4 L of oral rehydration solution 2
    • Continue replacing losses as long as diarrhea continues 2

Efficacy and Evidence

Bismuth subsalicylate has demonstrated moderate efficacy in treating diarrhea, though studies show loperamide is generally more effective:

  • In comparative studies, loperamide reduced the average number of unformed bowel movements more significantly than bismuth subsalicylate 3
  • Time to last unformed stool was significantly shorter with loperamide than with bismuth subsalicylate 3
  • Bismuth subsalicylate has shown a 62-76% effectiveness in preventing traveler's diarrhea 5

Special Considerations

  • Rehydration: Always drink plenty of clear fluids to prevent dehydration 1
  • Antimicrobial properties: Bismuth subsalicylate has direct antimicrobial effects and antisecretory properties 5
  • For H. pylori treatment: When used as part of bismuth quadruple therapy, the dosage is 2 tablets or capsules four times daily, 30 minutes before meals 2
  • Avoid in patients with: Aspirin allergy, bleeding disorders, or those taking anticoagulants

When to Seek Medical Attention

  • Diarrhea persisting beyond 48 hours despite treatment
  • Signs of severe dehydration (extreme thirst, dry mouth, little or no urination)
  • Bloody stools or high fever
  • Severe abdominal pain

Bismuth subsalicylate offers a safe and moderately effective option for treating acute diarrhea, though evidence suggests loperamide may provide faster and more effective relief for adults with non-infectious diarrhea 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bismuth subsalicylate in the treatment and prevention of diarrheal disease.

Drug intelligence & clinical pharmacy, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.